Anti-Actin antibody, MA1000, IHC(F) IHC(F): Mouse Intestine Tissue
Anti-Actin antibody, MA1000, IHC(F) IHC(F): Mouse Intestine Tissue
Anti-Actin ACTA1 Antibody (Monoclonal, AC-40)
MA1000
ApplicationsWestern Blot, ImmunoHistoChemistry
Product group Antibodies
ReactivityChicken, Human, Mouse, Rat
TargetACTA1
Overview
- SupplierBoster Bio
- Product NameAnti-Actin Antibody (Monoclonal, AC-40)
- Delivery Days Customer9
- Antibody SpecificityNo cross reactivity with other proteins.
- Application Supplier NoteOther applications have not been tested. Optimal dilutions should be determined by end users.
- ApplicationsWestern Blot, ImmunoHistoChemistry
- Applications SupplierIHF, WB, IHC
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDAC-40
- Concentration100 ug/ml
- FormulationLyophilized
- Gene ID58
- Target nameACTA1
- Target descriptionactin alpha 1, skeletal muscle
- Target synonymsACTA; actin, alpha skeletal muscle; ASMA; CFTD; CFTD1; CFTDM; MPFD; NEM1; NEM2; NEM3; nemaline myopathy type 3; SHPM
- HostMouse
- IsotypeIgG2a
- Protein IDP68133
- Protein NameActin, alpha skeletal muscle
- Scientific DescriptionBoster Bio Anti-Actin ACTA1 Antibody (Monoclonal, AC-40) catalog # MA1000. Tested in IHC, WB applications. This antibody reacts with Chicken, Human, Mouse, Rat.
- ReactivityChicken, Human, Mouse, Rat
- Reactivity SupplierChicken, Human, Mouse, Rat, Chicken
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203
References
- Aerobic exercise training alleviates renal injury in db/db mice through inhibiting Nox4-mediated NLRP3 inflammasome activation. Zhou Z et al., 2022 Oct 15, Exp GerontolRead more
- The mTOR-glycolytic pathway promotes T-cell immunobiology in oral lichen planus. Wang F et al., 2020 May, ImmunobiologyRead more
- Postinfarction Hearts Are Protected by Premature Senescent Cardiomyocytes Via GATA 4-Dependent CCN 1 Secretion. Cui S et al., 2018 Sep 18, J Am Heart AssocRead more
- Formaldehyde alters triglyceride synthesis and very low-density lipoprotein secretion in a time-dependent manner. Bai J et al., 2017 Dec, Environ Toxicol PharmacolRead more
- CXCR7 maintains osteosarcoma invasion after CXCR4 suppression in bone marrow microenvironment. Han Y et al., 2017 May, Tumour BiolRead more